Barrier Function Measurement in Dry Eye Patients After Using Systane Ultra for 30 Days

Alcon logo

Alcon

Status

Completed

Conditions

Dry Eye

Treatments

Other: Systane® Ultra

Study type

Interventional

Funder types

Industry

Identifiers

NCT00946777
SMA-09-04

Details and patient eligibility

About

The primary objective is to determine if there is a correlation between reductions in corneal staining and improvements in corneal barrier function.

Enrollment

19 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients must have moderate corneal staining and exhibit a need to use artificial tears.

Exclusion criteria

Patients can not participate in any other ophthalmic drug or device clinical trial within 30 days of the baseline visit.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

19 participants in 1 patient group

Systane® Ultra
Experimental group
Treatment:
Other: Systane® Ultra

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems